Overview

Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This post-marketing surveillance study was designed to supplement under conditions of normal clinical practice the data on the safety, tolerability and efficacy of Micardis® collected during the clinical studies.
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Telmisartan